(Q40578553)

21 September 2017

title

Treatment of intracranial metastatic esthesioneuroblastoma (English)

1 reference

21 September 2017

Marc C Chamberlain

1

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

21 September 2017

1 reference

21 September 2017

volume

95

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

243-248

1 reference

Olfactory neuroblastoma—A clinical analysis of 17 cases

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

Esthesioneuroblastoma: reflections of a 21-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

Late intracranial metastasis from esthesioneuroblastoma: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

Involved-field radiotherapy and intra-Ommaya methotrexate/cytarabine in patients with AIDS-related lymphomatous meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

Primitive neuroectodermal tumors of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

Chronic oral VP-16 for recurrent medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

Response of recurrent medulloblastoma to low-dose oral etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

Esthesioneuroblastoma: The University of Iowa Experience 1978-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

21 January 2018

Esthesioneuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10679

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.10679

1 reference

21 September 2017

1 reference